POSTERIOR TIBIAL TENDON DYSFUNCTION

POSTERIOR TIBIAL TENDON DYSFUNCTION was reported 28 times

POSTERIOR TIBIAL TENDON DYSFUNCTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Adenosine Receptor Agonist [EPC] 1 0.0001
1 Hedgehog Pathway Inhibitor [EPC] 1 0.0001
2 Potassium Binder [EPC] 1 0.0001
3 Vitamin D3 Analog [EPC] 1 0.0000
4 Provitamin D2 Compound [EPC] 1 0.0000
5 Fluoroquinolone Antibacterial [EPC] 4 0.0000
6 General Anesthetic [EPC] 1 0.0000
7 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
8 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
9 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
10 Vitamin D [EPC] 4 0.0000
11 Aldosterone Antagonist [EPC] 2 0.0000
12 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
13 Antirheumatic Agent [EPC] 1 0.0000
14 Vitamin B12 [EPC] 3 0.0000
15 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
16 Aromatase Inhibitor [EPC] 1 0.0000
17 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
18 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
19 Vitamin C [EPC] 3 0.0000
20 Azole Antifungal [EPC] 1 0.0000
21 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
22 Janus Kinase Inhibitor [EPC] 1 0.0000
23 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
24 Expectorant [EPC] 1 0.0000
25 Corticosteroid [EPC] 6 0.0000
26 Insulin Analog [EPC] 2 0.0000
27 Platinum-based Drug [EPC] 1 0.0000
28 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
29 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
31 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
33 Atypical Antipsychotic [EPC] 1 0.0000
34 Thalidomide Analog [EPC] 1 0.0000
35 Kinase Inhibitor [EPC] 1 0.0000